Precigen Logo

Precigen

🇺🇸
PGEN
US74017N1054

Precigen is an innovative US-based biotechnology company specializing in the development of advanced gene therapies. Through cutting-edge precision medicine platforms, Precigen is revolutionizing the treatment of cancer, as well as autoimmune and infectious diseases.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
After-Hours
In 70 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Precigen report its next quarterly earnings?

Precigen is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Precigen last report quarterly earnings?

Precigen last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at 0.05 USD.

How does Precigen stock react to earnings?

Across its last 3 earnings reports, Precigen stock moved by ±13.9% on average the following day. The largest reaction was +25.5% on 03/25/2026; 3 of 3 reactions were positive.

How often has Precigen beaten expectations?

Precigen has beaten analyst EPS estimates in 5 of its last 6 evaluated quarters (beat rate: 83.3%).

How do I add the Precigen earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.00
Actual:
Q2 2026
Beat
Estimate:-$0.01
Actual:$0.05
Difference:+$0.06
Price reaction (1 day):+5.5 %
Price reaction (7 days):+5.1 %
Q1 2026
Beat
Estimate:-$0.03
Actual:-$0.02
Difference:+$0.01
Price reaction (1 day):+10.8 %
Price reaction (7 days):+2.9 %
Q4 2025
Beat
Estimate:-$0.08
Actual:-$0.07
Difference:+$0.01
Price reaction (1 day):+25.5 %
Price reaction (7 days):+26.8 %
Q3 2025
Beat
Estimate:-$0.08
Actual:-$0.01
Difference:+$0.07
Q2 2025
Missed
Estimate:-$0.10
Actual:-$1.06
Difference:-$0.97
Q1 2025
Beat
Estimate:-$0.08
Actual:-$0.08
Difference:+$0.00

Earnings statistics

Stock reaction to earnings

±13.9%
Avg. next-day move
+25.5%
Largest move (03/25/2026)
100%
Share of positive reactions
±11.6%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

5/6
Quarters above estimates
83.3%
Beat rate
+93.2%
Avg. EPS surprise

Basis: 6 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Precigen
Ticker Symbol
PGEN
ISIN
US74017N1054
Country
🇺🇸
USA
Sector
More Financial Information